Adaptimmune Therapeutics Correlations

ADAP Stock

USD 0.66 0.02 3.13%

The current 90-days correlation between Adaptimmune Therapeutics and Black Diamond Therapeutics is 0.43 (i.e., Very weak diversification). The correlation of Adaptimmune Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Adaptimmune Therapeutics Correlation With Market

Good diversification

The correlation between Adaptimmune Therapeutics Plc and DJI is -0.14 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adaptimmune Therapeutics Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Moving together with Adaptimmune Stock

0.7	ME	23Andme Holding	Pair Corr
0.74	VALN	Valneva SE ADR	Pair Corr
0.71	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.79	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.65	IPSC	Century Therapeutics	Pair Corr
0.71	MTEM	Molecular Templates	Pair Corr
0.82	NKTX	Nkarta Inc	Pair Corr
0.66	TPST	Tempest Therapeutics	Pair Corr
0.74	AGL	agilon health	Pair Corr
0.68	CYRX	Cryoport	Pair Corr
0.71	EC	Ecopetrol SA ADR	Pair Corr
0.72	HYMTF	Hyundai Motor	Pair Corr
0.7	TLK	Telkom Indonesia Tbk	Pair Corr

Moving against Adaptimmune Stock

0.58	KZR	Kezar Life Sciences	Pair Corr
0.36	MLYS	Mineralys Therapeutics,	Pair Corr
0.33	MDGL	Madrigal Pharmaceuticals	Pair Corr
0.78	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.73	CVX	Chevron Corp Fiscal Year End 7th of February 2025	Pair Corr
0.72	BAC	Bank of America Fiscal Year End 10th of January 2025	Pair Corr
0.7	INTC	Intel Fiscal Year End 23rd of January 2025	Pair Corr
0.7	T	ATT Inc Aggressive Push	Pair Corr
0.68	HPQ	HP Inc	Pair Corr
0.65	HD	Home Depot	Pair Corr
0.64	CAT	Caterpillar Fiscal Year End 3rd of February 2025	Pair Corr
0.62	JPM	JPMorgan Chase Fiscal Year End 10th of January 2025	Pair Corr
0.53	VFS	VinFast Auto Earnings Call Tomorrow	Pair Corr
0.5	KB	KB Financial Group	Pair Corr

Related Correlations Analysis

	STOK	FIXX	BDTX	HARP	MREO	PIRS	PDSB	LPTX	AFMD	CRVS
STOK		0.0	0.74	0.0	0.48	0.48	0.05	0.1	0.84	-0.46	STOK
FIXX	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FIXX
BDTX	0.74	0.0		0.0	0.61	0.59	0.25	-0.2	0.75	-0.87	BDTX
HARP	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	HARP
MREO	0.48	0.0	0.61	0.0		0.62	0.62	0.01	0.54	-0.51	MREO
PIRS	0.48	0.0	0.59	0.0	0.62		0.22	0.27	0.52	-0.39	PIRS
PDSB	0.05	0.0	0.25	0.0	0.62	0.22		0.02	0.2	-0.35	PDSB
LPTX	0.1	0.0	-0.2	0.0	0.01	0.27	0.02		0.2	0.5	LPTX
AFMD	0.84	0.0	0.75	0.0	0.54	0.52	0.2	0.2		-0.45	AFMD
CRVS	-0.46	0.0	-0.87	0.0	-0.51	-0.39	-0.35	0.5	-0.45		CRVS
	STOK	FIXX	BDTX	HARP	MREO	PIRS	PDSB	LPTX	AFMD	CRVS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

AFMD	+ 0.84	STOK
AFMD	+ 0.75	BDTX
BDTX	+ 0.74	STOK
PIRS	+ 0.62	MREO
PDSB	+ 0.62	MREO
MREO	+ 0.61	BDTX

High negative correlations

CRVS	- 0.87	BDTX
CRVS	- 0.51	MREO
CRVS	- 0.46	STOK
CRVS	- 0.45	AFMD
CRVS	- 0.39	PIRS
CRVS	- 0.35	PDSB

Risk-Adjusted Indicators

There is a big difference between Adaptimmune Stock performing well and Adaptimmune Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Adaptimmune Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
STOK	2.63	(0.23)	0.00	2.28	0.00	0.00	4.68	(6.99)	21.35
FIXX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
BDTX	3.57	(1.30)	0.00	8.10	0.00	0.00	5.47	(8.30)	19.51
HARP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MREO	2.59	(0.35)	0.00	(11.21)	0.00	0.00	4.80	(5.79)	17.36
PIRS	1.58	(0.05)	0.00	0.31	0.00	0.00	3.23	(3.40)	12.92
PDSB	3.32	(0.49)	0.00	2.25	0.00	0.00	7.67	(6.76)	31.83
LPTX	3.71	(0.02)	0.00	0.15	0.00	0.00	11.08	(7.03)	25.59
AFMD	2.49	(0.73)	0.00	(1.68)	0.00	0.00	6.39	(6.82)	21.26
CRVS	3.64	1.40	0.29	(3.12)	3.02	(4.20)	9.38	(4.88)	23.11

Adaptimmune Therapeutics Corporate Management

Kerry Sharp	Senior Council	Profile
Dennis Williams	Senior Development	Profile
Sbastien Desprez	VP Affairs	Profile
Dana Lynch	Senior Communications	Profile
Helen MBA	CoFounder Officer	Profile
Bertrand Esq	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC